XIENCE

A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II

A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-coated Stents and the Xience Drug-eluting Stent System in Patients With Acute Coronary Syndrome and High Bleeding Risk Using Optical Coherence Tomography

A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI

Absorb IV Randomized Controlled Trial

ABSORB III Randomized Controlled Trial (RCT)

XIENCE 28 USA Study

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

XIENCE 28 Global Study

Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent

A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention

Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial

ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis in Patients at High Risk of Restenosis

Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)